Construction of a New Fusion Protein Vector Associated to Fibronectin Binding Protein A and Clumping Factor A Derived from Staphylococcus aureus NCTC8325

Document Type : Original Article


1 Department of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Biotechnology, Pasteur Institute of Iran, Tehran, Iran

3 Department of Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran


Staphylococcus aureus is a leading cause of many nosocomial and community acquired infections. According to many reports, antibiotic therapy can not guarantee the eradication of S. aureus infections. Thus designing an adhesin based vaccine could restrain the S. aureus infections. This study designed for construction of a new fusion protein vaccine against S. aureus infections based on adhesin molecules fibronectin binding protein A (FnBPA) and clumping factor A (ClfA).
Materials and Methods
Bioinformatic experiments were performed using Oligo analyzer and DNAMAN softwares. The fragments corresponding to fnbA binding domain and a C-terminal fragment from clfA were amplified from S. aureus NCTC8325 genomic DNA. Purified PCR products and the vector, pET15b, were digested with Nco\ and BamHI. The digested PCR products were hybridized together and then ligated to digested vector. Finally incomplete construct was assembled by Taq DNA polymerase. To quick confirmation of cloning procedure the new construct designated pfnbA-clfA was digested with Ncol and BamHI. To further verification, the product was sent for sequencing.
The data based on bioinformatic analysis showed no homology between fusion protein and human proteins. Digestion of new vector with Ncol and BamHI confirmed the ligation of fusion protein sequence into pET15b. Sequencing results verified the integrity of target sequences.
This study is the first effort to construct a new fusion protein vector based on S. aureus adhesins using a new design. This project is being continued to study the expression and biological activity of the fusion protein in a cell culture model.


1.Archer GL, Climo MW. Staphylococcus aureus bacteremia - consider the source. N Engl J Med 2001; 344: 55-56.
2.Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-1791.
3.Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high- level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003; 302: 1569-1571.
4.Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin- resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-1347.
5.Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB .Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-Like vanA plasmids in michigan. Antimicrob Agents Chemother 2008; 52: 452-457.
6.Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998; 6: 484-488.
7.Patti JM, Allen BL, McGavin MJ, Ho'o'k M. MSCRAMM mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994; 48: 585-617.
8.Ingham KC, Brew S, Vaz D, Sauder DN, McGavin MJ. Interaction of Staphylococcus aureus fibronectin- binding protein with fibronectin. J Biol Chem 2004; 279: 42945-42953.
9.Rice K , Huesca M, Vaz D, Mcgavin MJ. Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus. Infect Immun 2001; 69: 791-3799.
10.Patti JM, Ho'o'k M. Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol 1994; 6: 752-758.
11.Dziewanowska K, Patti JM, Deobald CF, Bayles KW, Trumble WR, Bohach GA. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun 1999; 67: 4673-4678.
12.Kuypers JM, Proctor RA. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun 1989; 57: 2306-2312.
13.Mempel M, Schmidt T, Weidinger S, Schnopp C, Foster T, Ring J, et al. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol 1998; 111: 452-456.
14.Peacock SJ, Foster TJ, Cameron BJ, Berendt AR. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 1999; 145: 3477-3486.
15.Vaudaux P, Pittet D, Haeberli A, Lerch PG, Morgenthaler JJ, Proctor RA, et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis 1993; 167: 633-641.
16.Brennan FR, Jones TD, Longstaff M, Chapman S, Bellaby T, Smith H, et al. Immunogenicity of peptides derived from a fibronectin-binding protein of Staphylococcus aureus expressed on two different plant viruses. Vaccine 1999; 17: 1846-1857.
17.Huesca M, Sun Q, Peralta R, Shivji GM, Sauder DN, McGavin MJ. Synthetic peptide immunogens elicit polyclonal and monoclonal antibodies specific for linear epitopes in the D motifs of Staphylococcus aureus fibronectin-binding protein, which are composed of amino acids that are essential for fibronectin binding. Infect Immun 2000; 68: 1156-1163.
18.Jo'nsson K, Signa's C, Muller HP, Lindberg M. Two different genes encode fibronectin binding proteins in Staphylococcus aureus: the complete nucleotide sequence and characterization of the second gene. Eur J Biochem 1991; 202: 1014-1048.
19.Signa s C, Raucci G, Jo'nsson K, Lindgren PE, Anantharamaiah GM, Ho'o'k M, et al. Nucleotide sequence of the gene for a fibronectin binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci 1989; 86: 699-703. 
20.Sun Q, Smith GM, Zahradka C, McGavin MJ. Identification of D Motif Epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding. Infect Immun 1997: 537-543
21.Huff S, Matsuka YV, McGavin MJ, Ingham.KC. Interaction of N-terminal fragments of fibronectin with synthetic and recombinant Dmotifs from its binding protein on Staphylococcus aureus studied using fluorescence anisotropy. J Biol Chem 1994; 269: 15563-15570.
22.McGavin MJ, Gurusiddappa S, Lindgren PE, Lindberg M, Ho'o'k M. Fibronectin receptors from Streptococcus dysgalactiae and Staphylococcus aureus: involvement of conserved residues in ligand binding. J Biol Chem 1993; 268: 23946-23953.
23.McGavin MG, Raucci G, Gurusiddappa S, Ho'o'k M. Fibronectin binding determinants of the Staphylococcus aureus fibronectin receptor. J Biol Chem 1991; 266: 8343-8347.
24.Siboo IR, Cheung AL, Bayer AS, Sullam PM. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 2001; 69: 3120-3127.
25.Moreillon PJ, Entenza M, Francioli P, McDevitt D, Foster TJ, Francois P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63: 4738-4743.
26.Que YA, Haefliger JA, Francioli P, Moreillon P. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect. Immun 2000; 68: 3516-3522.
27.Stutzmann Meier P, Entenza JM, Vaudaux P, Francioli P, Glauser MP, Moreillon P. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun 2001; 69: 657-664.
28. Colque-Navarro P, Palma M, So'derquist B, Flock JI, Mo'llby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol 2000; 7:14-20.
29.Wolz C, Goerke C, Landmann R, Zimmerli W, Fluckiger U. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 2002; 70: 2758-2762.
30.McDevitt D, Francois, P Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surface- located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol 1995; 16: 895-907.
31.Josefsson E, Higgins J, Foster TJ, Tarkowski A. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. Plos One 2008; 3: e2206.
32.Josefsson EO, Hartford, O’Brien LO, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001; 184: 1572-1580.
33.Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
34.Hall AE, Domanski PJ, Patel PR, Vernachio JH, Syribeys PJ, Gorovits EL et al. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun 2003; 71: 6864-6870.
35.Arrecubieta C, Asai T, Bayern M, Loughman A, Fitzgerald JR, Shelton CE, Baron HM, Dang NC, Deng MC, Naka Y, Foster TJ, Lowy FD. The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis. 2006; 193: 1109-19.
36.Haggar A, Hussain M, Lonnies H, Herrmann M, Norrby-Teglund A, Flock JI. Extracellular adherence protein from Staphylococcus aureus enhances internalization into Eukaryotic Cell. Infect Immun 2003; 71: 2310-2317.
37.Loughman A, Sweeney T, Keane FM, Pietrocola G, Speziale P, Foster TJ . Sequence diversity in the A domain of Staphylococcus aureus fibronectin-binding protein A. BMC Microbiol 2008; 8: 74